Quality of life in patients with locally advanced prostate cancer given endocrine treatment with or without radiotherapy: 4-year follow-up of SPCG-7/SFUO-3, an open-label, randomised, phase III trial.
about
Patient-reported outcomes in randomised controlled trials of prostate cancer: methodological quality and impact on clinical decision makingEarly detection and management of symptoms using an interactive smartphone application (Interaktor) during radiotherapy for prostate cancer.Effects of an interactive mHealth innovation for early detection of patient-reported symptom distress with focus on participatory care: protocol for a study based on prospective, randomised, controlled trials in patients with prostate and breast canImpaired health-related quality of life after chemoradiotherapy for anal cancer: late effects in a national cohort of 128 survivors.Prospective assessment of urinary, gastrointestinal and sexual symptoms before, during and after image-guided volumetric modulated arc therapy for prostate cancer.Are there specific health-related factors that can accentuate the risk of suicide among men with prostate cancer?Multimodal approaches to high-risk prostate cancer.Recommended patient-reported core set of symptoms to measure in prostate cancer treatment trials.Radical prostatectomy for high-risk clinically localized prostate cancer: a prospective single institution series.Impact of Radiotherapy When Added to Androgen-Deprivation Therapy for Locally Advanced Prostate Cancer: Long-Term Quality-of-Life Outcomes From the NCIC CTG PR3/MRC PR07 Randomized Trial.Improved survival with the addition of radiotherapy to androgen deprivation: questions answered and a review of current controversies in radiotherapy for non-metastatic prostate cancer.Patient Reported Outcome Measure (PROM) of Quality of Life After Prostatectomy - Results from a 5-Year Study.Rationale for stereotactic body radiation therapy in treating patients with oligometastatic hormone-naïve prostate cancer.The status of surgery in the management of high-risk prostate cancer.Consequential late effects after radiotherapy for prostate cancer - a prospective longitudinal quality of life study.Work ability in prostate cancer survivors after radical prostatectomy.The importance of combined radiation and endocrine therapy in locally advanced prostate cancer.Radical prostatectomy in clinically localized high-risk prostate cancer: outcome of 231 consecutive patients.Side-effects of post-treatment biopsies in prostate cancer patients treated with endocrine therapy alone or combined with radical radiotherapy in the Scandinavian Prostate Cancer Group-7 randomized trial.Assessment of quality of life in advanced, metastatic prostate cancer: an overview of randomized phase III trials.Fatigue and other adverse effects in men treated by pelvic radiation and long-term androgen deprivation for locally advanced prostate cancer.Adding intensity-modulated radiotherapy to the pelvis does not worsen the adverse effect profiles compared to limited field radiotherapy in men with prostate cancer at 12-month follow-up.Receipt of definitive therapy in elderly patients with unfavorable-risk prostate cancer.State of Science Conference in Cancer Care – identification of front line research topicsDose to penile bulb is not associated with erectile dysfunction 18 months post radiotherapy: A secondary analysis of a randomized trial
P2860
Q26852751-3FB6103B-0EF1-4EB0-82FB-2587009ECEA8Q33452936-29C4C5F1-F353-4167-9825-2A3223C25E13Q33455397-709DD3FD-5959-4166-A6CC-264282F14846Q33457264-98EE30D3-9117-43DE-A2A2-0A0FF126D7F2Q33461489-1B9A5BE4-64CF-441B-8A90-94EC26D68F2EQ33561281-C6426A0F-3A40-4C87-9385-949B3D394169Q34111597-4E64AC2E-73FB-4ED3-AF0B-F45DAC52180EQ34315605-23E38629-B1D7-4AEC-B7B0-804BFFAF6D88Q35605772-181A6E79-EA0D-4DF3-8310-367DEC879B7AQ35771173-21649F00-7BDD-42AD-A36A-5A80E27423A3Q36474222-73D69236-3F3A-4850-AFC3-149488E6F732Q37486346-E512A454-29E8-47BC-ACA1-235A76324A1AQ38172209-DA2693EE-6453-42C7-BDA1-86D749988A83Q38211115-478A75AF-5322-41BB-8EC0-E35A158B6BE9Q40130646-57431833-2762-4828-89C6-BB4087C8EBF0Q40272066-9CA60684-7100-4342-9713-FB982429274DQ42140746-AED64BC8-A2FE-4F82-A3A2-68560A1F0604Q43437975-49DEEC21-41BD-44D3-842E-955ECEE39433Q43936925-F3C92B50-D4DA-4721-AA1D-5110A206BA44Q47644799-EFBF3259-F9F9-404D-96F7-912232576638Q47802807-D4AC1D7B-2335-464F-A523-0FDB14A3319CQ48075929-22DB1BB8-AA3F-4B34-976D-29CCEBE846B5Q48194820-6986278A-5221-4AEB-B46D-D9F6895F8314Q57423031-311A3C10-C35A-408E-BFBD-A0DD826AFAFCQ58604473-7E868934-29AF-49FC-8BF5-E5D6ED8A8B5F
P2860
Quality of life in patients with locally advanced prostate cancer given endocrine treatment with or without radiotherapy: 4-year follow-up of SPCG-7/SFUO-3, an open-label, randomised, phase III trial.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Quality of life in patients wi ...... , randomised, phase III trial.
@en
Quality of life in patients wi ...... , randomised, phase III trial.
@nl
type
label
Quality of life in patients wi ...... , randomised, phase III trial.
@en
Quality of life in patients wi ...... , randomised, phase III trial.
@nl
prefLabel
Quality of life in patients wi ...... , randomised, phase III trial.
@en
Quality of life in patients wi ...... , randomised, phase III trial.
@nl
P2093
P921
P1433
P1476
Quality of life in patients wi ...... , randomised, phase III trial.
@en
P2093
Anders Widmark
Fredrik Wiklund
Jan-Erik Damber
Jo-Asmund Lund
Olbjörn Klepp
Per Fransson
Scandinavian Prostate Cancer Group Study 7
Swedish Association for Urological Oncology 3
P304
P356
10.1016/S1470-2045(09)70027-0
P577
2009-03-13T00:00:00Z